Private Harbour Investment Management & Counsel’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Private Harbour Investment Management & Counsel’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-28,634	Closed	-$3.26M	–	47
2022 Q4	$3.26M	Hold	28,634	–	–	3.59%	6
2022 Q3	$1.77M	Sell	28,634 -1,755	-6%	-$123K	2.05%	17
2022 Q2	$2.42M	Sell	30,389 -1,082	-3%	-$102K	2.69%	11
2022 Q1	$3.31M	Sell	31,471 -731	-2%	-$71.2K	2.77%	11
2021 Q4	$3.47M	Sell	32,202 -62	-0.2%	-$6.76K	2.77%	10
2021 Q3	$3.53M	Sell	32,264 -537	-2%	-$55.7K	3.11%	8
2021 Q2	$3.07M	Sell	32,801 -1,232	-4%	-$113K	2.7%	10
2021 Q1	$3.13M	Sell	34,033 -750	-2%	-$63.3K	2.84%	9
2020 Q4	$2.54M	Sell	34,783 -500	-1%	-$37.2K	2.52%	12
2020 Q3	$2.74M	Buy	35,283 +70	+0.2%	+$4.82K	2.9%	7
2020 Q2	$1.96M	Sell	35,213 -127	-0.4%	-$5.43K	2.13%	16
2020 Q1	$1.05M	Buy	+35,340	New	+$1.2M	1.23%	39

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Private Harbour Investment Management & Counsel's HZNP Position: Q1 2023 in Review

Private Harbour Investment Management & Counsel sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 28,634 shares — an estimated $3.26M sold.

Private Harbour Investment Management & Counsel first reported a position in HZNP in Q1 2020 and held it in 12 quarters. The position peaked at $3.53M in Q3 2021. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

Private Harbour Investment Management & Counsel reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Private Harbour Investment Management & Counsel sold 28,634 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $3.26M.
Private Harbour Investment Management & Counsel first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2020 and held it in 12 quarters.
Private Harbour Investment Management & Counsel's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $3.53M in Q3 2021.
553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Private Harbour Investment Management & Counsel's 13F filing for Q1 2023, filed 18 Apr 2023.